|
|
Drugs for Isolated Growth Hormone Deficiency (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 195)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Selenium | approved, vet_approved | Phase 4 | 180 | 7782-49-2 | | Selanediide Selen Selenide Selenide(2-) Selenio | Selenium Selenium elemental Selenium ion (Se2+) Selenium metallicum Selenium, elemental Sélénium | |
| | 2 | | Trace Elements | | Phase 4, Phase 1, Phase 2 | 6001 | | | | 3 | | Insulin, Globin Zinc | | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 4645 | | | | 4 | | Mitogens | | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1617 | | | | 5 | | Hormone Antagonists | | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 13180 | | | | 6 | | Protective Agents | | Phase 4 | 7443 | | | | 7 | | insulin | | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 4646 | | | | 8 | | Antioxidants | | Phase 4 | 3050 | | | | 9 | | Hormones, Hormone Substitutes, and Hormone Antagonists | | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 13168 | | | | 10 | | Micronutrients | | Phase 4, Phase 1, Phase 2 | 6001 | | | | 11 | | Hormones | | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 14415 | | | | 12 | | Pharmaceutical Solutions | | Phase 4, Phase 3, Phase 2 | 8192 | | | | 13 | | methionine | Nutraceutical | Phase 4 | 88 | | | | 14 | | Zinc | approved | Phase 3, Early Phase 1 | 2296 | 7440-66-6 | 32051, 23994 | | | 15 | | Hydrocortisone | approved, vet_approved | Phase 2, Phase 3, Early Phase 1 | 667 | 50-23-7 | 5754, 657311 | (11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione (11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione 11-Hydrocortisone 11-beta-Hydrocortisone 11-beta-Hydroxycortisone 11a-Hydroxycorticosterone 11alpha-Hydroxycorticosterone 11b,17,21-Trihydroxyprogesterone 11b-Hydrocortisone 11b-Hydroxycortisone 11beta,17,21-Trihydroxyprogesterone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione 11beta-Hydrocortisone 11beta-Hydroxycortisone 11beta-hydrocortisone 11β-hydrocortisone 17-Hydroxycorticosterone 17a-Hydroxycorticosterone 17alpha-Hydroxycorticosterone 2v95 4-Pregnen-11beta,17alpha,21-triol-3,20-dione 4-Pregnene-11alpha,21-triol 3,20-dione 4-Pregnene-11b,17a,21-triol-3,20-dione 50-23-7 8056-08-4 80562-38-5 8063-42-1 AC-12902 AC1L1L2B ACETASOL HC ACETIC ACID W/ HYDROCORTISONE AI3-25006 AKOS001582651 Acticort Acticort (TN) Aeroseb HC Aeroseb-HC Ala-Cort Ala-Scalp Alacort Algicirtis Alphaderm Amberin Anflam Anti-inflammatory hormone Anucort Anucort-HC Anusol HC Anusol HC (TN) Aquacort Aquanil HC B48448A1-24BA-47CA-8D9E-43E5BC949386 BPBio1_000544 BRD-K93568044-001-03-1 BSPBio_000494 Balneol-hc Barseb HC Basan-Corti Beta-hc Bio-0648 C00735 C21H30O5 CCRIS 5854 CHEBI:17650 CHEMBL389621 CID5754 COR-OTICIN CPD000653523 CaldeCORT Spray Cetacort Chronocort Clear aid Cleiton Cobadex Colocort Colocort (TN) Compound F Compound F (kendall) Cor-Tar-Quin Corhydron Cort-Dome Cort-Quin Cortanal Cortef Cortef (TN) Cortenema Cortesal Corticreme Cortifair Cortifan Cortifoam Cortiment Cortisol Cortisol alcohol Cortisol, Hydrocortisone Cortisolonum Cortisporin Cortisporin Otico Cortispray Cortizol Cortolotion Cortonema Cortoxide Cortril Cremesone Cremicort-H Cutisol Cyclodextrin-encapsulated hydrocortisone D00088 DB00741 DB07886 Delacort Derm-Aid Dermacort Dermaspray Dermil Dermocortal Dermolate Dihydrocostisone Dioderm Dome-cort Domolene-HC Drotic DuoCort EINECS 200-020-1 EU-0100594 Ef corlin Efcorbin Efcortelan Efcortelin Eldecort Eldercort Epicort Epicortisol Epiderm H Esiderm H Evacort Ficortril Fiocortril Flexicort Foille Insetti Genacort Genacort (lotion) Glycort Gyno-Cortisone H 4001 H-Cort H0135_SIGMA H0396_SIGMA H0888_SIGMA H3160_SIGMA H4001_SIGMA H6909_SIGMA HC HC #1 | HC #4 HC (HYDROCORTISONE) HMS1569I16 HMS2090M04 HSDB 3339 HYDROCORTISONE AND ACETIC ACID HYDROCORTISONE IN ABSORBASE Heb Cort Heb-Cort Hi-cor Hidalone Hidro-Colisona Hidrocortisona Hidrocortisona [INN-Spanish] Hycort Hycortol Hycortole Hydracort Hydrasson Hydro-Adreson Hydro-Colisona Hydro-RX Hydro-colisona Hydrocort Hydrocortal Hydrocorticosterone Hydrocortisone Hydrocortisone (JP15/USP/INN) Hydrocortisone Acetate Hydrocortisone Base Hydrocortisone Butyrate Hydrocortisone Sodium Phosphate Hydrocortisone Valerate Hydrocortisone [INN:BAN:JAN] Hydrocortisone alcohol Hydrocortisone base Hydrocortisone free alcohol Hydrocortisone solution Hydrocortisone-Water Soluble Hydrocortisonum Hydrocortisonum [INN-Latin] Hydrocortistab Hydrocortisyl Hydrocortone Hydroskin Hydroxycortisone Hysone Hytisone Hytone Hytone (TN) Hytone lotion Idrocortisone Idrocortisone [DCIT] Incortin-H Incortin-hydrogen Kendall'S compound F Kendall's compound F Komed HC Kyypakkaus LMST02030001 LS-7439 Lacticare HC Lacticare-HC Lactisona Lopac0_000594 Lubricort MLS000069609 MLS001148103 MLS002207135 MLS002222189 Maintasone Medicort Meusicort Mildison Milliderm MolPort-001-794-637 NCGC00022848-06 NCGC00022848-07 NCGC00022848-09 NCGC00022848-12 NCI60_000118 NSC 10483 NSC-10483 NSC10483 Neo-Cort-Dome Neo-Cortef Neosporin-H Ear Nogenic HC Nutracort Nystaform-HC ORLEX HC Optef Otalgine Otic-Neo-Cort-Dome Otobiotic Otocort Otosone-F Pediotic Suspension Penecort Permicort Polcort H Preparation H Hydrocortisone Cream Prepcort Prestwick0_000447 Prestwick1_000447 Prestwick2_000447 Prestwick3_000447 Prestwick_265 Prevex HC Proctocort Proctofoam Proctozone HC Protocort Racet Rectasol-HC Rectoid Reichstein'S substance M Reichstein's substance M Remederm HC S1696_Selleck SAM002264617 SMP1_000156 SMR000059022 SMR000653523 SPBio_002433 Sanatison Scalp-Cort Scalpicin Capilar Schericur Scheroson F Sigmacort Signef Stie-cort Stiefcorcil Synacort Systral Hydrocort Tarcortin Texacort Texacort lotion 25 Timocort Topicort Transderma H Traumaide UNII-WI4X0X7BPJ UPCMLD-DP133 UPCMLD-DP133:001 Uniderm Vioform-Hydrocortisone VoSol HC Vytone Zenoxone [3H]cortisol component of Lubricort component of Neo-Cort-Dome component of Otalgine hydrocortisone | |
| | 16 | | Clonidine | approved | Phase 3 | 240 | 4205-90-7 | 2803 | 1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI) 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine 2,6-dichloro-N-(2-imidazolidinylidene)aniline 2,6-dichloro-N-2-imidazolidinylidenebenzenamide 2,6-dichloro-N-imidazolidin-2-ylideneaniline 2-((2,6-Dichlorophenyl)imino)imidazolidine 2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2) 2-(2,6-Dichloroanilino)-2-imidazoline 2-(2,6-Dichlorophenylamino)-2-imidazoline 2-(2,6-Dichlorophenylimino)imidazolidine 2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI) 2-[(2,6-Dichlorophenyl)imino]imidazoline 2-[(2,6-dichlorophenyl)imino]-2-imidazoline 4205-90-7 4205-91-8 (mono-hydrochloride) 57066-25-8 734571A AB00514634 AC1L1EI5 AC1Q3K6V AKOS001595470 Adesipress BIDD:GT0547 BPBio1_000040 BRD-K98530306-001-02-1 BRD-K98530306-003-05-0 BSPBio_000036 BSPBio_001588 BSPBio_002055 Bio1_000470 Bio1_000959 Bio1_001448 Bio2_000308 Bio2_000788 C9H9Cl2N3 CAS-4205-91-8 CATAPRES-TTS-1 CATAPRES-TTS-2 CATAPRES-TTS-3 CCRIS 7787 CHEBI:3757 CHEBI:46632 CHEMBL134 CID2803 Catapres Catapres- TTS Catapres-TTS Catapresan Catapressan Catarpres Catarpres-TTS Catarpres-TTS (TN) Catarpresan Chlofazoline Chlornidinum Clofenil Clonidin Clonidina Clonidina [INN-Spanish] Clonidine (JAN/USAN/INN) Clonidine HCl Clonidine [USAN:BAN:INN] Clonidinhydrochlorid Clonidinum Clonidinum [INN-Latin] Clonistada Clopheline D00281 DB00575 DB07566 DivK1c_000774 | Dixarit Duraclon Duraclont EINECS 224-119-4 Gemiton HMS1361P10 HMS1791P10 HMS1989P10 HMS2089G11 HSDB 3040 Hemiton IDI1_000774 IDI1_034058 Ipotensium Isoglaucon KBio1_000774 KBio2_000308 KBio2_001821 KBio2_002876 KBio2_004389 KBio2_005444 KBio2_006957 KBio3_000615 KBio3_000616 KBio3_001275 KBioGR_000308 KBioGR_001572 KBioSS_000308 KBioSS_001821 Klofelin Klofenil L000193 LS-79606 Lopac-C-7897 Lopac0_000268 M 5041T M-5041T MolPort-001-779-668 MolPort-005-932-374 N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine NCGC00015268-01 NCGC00015268-02 NCGC00015268-08 NCGC00024734-01 NCGC00024734-02 NCGC00024734-03 NCGC00024734-04 NCGC00024734-05 NCGC00179680-01 NINDS_000774 Prestwick0_000248 Prestwick1_000248 Prestwick2_000248 Prestwick3_000248 SKF 34427 SPBio_001233 SPBio_002255 ST 155BS ST-155-BS ST-155BS Spectrum2_001187 Spectrum3_000358 Spectrum4_000956 Spectrum5_000759 Spectrum_001341 T171 Tenso-Timelets Tocris-0690 UNII-MN3L5RMN02 ZINC00896484 clonidine nchembio.79-comp11 nchembio705-10 |
| | 17 | | Anastrozole | approved, investigational | Phase 2, Phase 3 | 279 | 120511-73-1 | 2187 | .alpha.,alpha.,.alpha.',.alpha.'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile 1,3-benzenediacetonitrile, a, a, a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl) 120511-73-1 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile) 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile) 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile) 2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile AC-4234 AC1L1D49 Anastrazole Anastrole Anastrozol Anastrozole (JAN/USAN/INN) Anastrozole [USAN:INN:BAN] Arimidex Arimidex (TN) Arimidex (Zeneca) Arimidex, Anastrozole Asiolex Astra brand of anastrozole AstraZeneca brand of anastrozole C08159 C090450 C17H19N5 CHEBI:2704 CHEMBL1399 CID2187 CPD000466301 | D00960 DB01217 HMS2052M11 HMS2089N10 HSDB 7462 I06-0021 ICI D1033 ICI-D 1033 ICI-D1033 LS-29563 MLS000759396 MLS001424217 MolPort-005-933-078 NCGC00164619-01 NSC719344 S1188_Selleck SAM001246525 SBB066057 SMR000466301 UNII-2Z07MYW1AZ ZD 1033 ZD-1033 ZD1033 ZINC00000941 Zeneca ZD 1033 Zeneca brand of anastrozole alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile anastrazole anastrozole |
| | 18 | | Benzocaine | approved | Phase 3 | 2016 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthone BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Bensokain Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Caswell No. 430A Chloraseptic D001566 D00552 DB01086 Dermoplast Diet Ayds DivK1c_000932 E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA | Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Formate, Benzocaine HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Hurricaine Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Keloform LS-35847 MLS001331704 MLS002153970 Methanesulfonate, Benzocaine MolPort-000-871-526 NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Norcain Norcaine Norcainum Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orthesin Otocain Outgro Parathesin Parathesin (TN) Parathesine Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Topcaine UNII-U3RSY48JW5 WLN: ZR DVO2 ZINC12358719 benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline | |
| | 19 | | Epinephrine | approved, vet_approved | Phase 2, Phase 3 | 985 | 51-43-4 | 5816 | (-)-(R)-Epinephrine (-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol (-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol (-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol (-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol (-)-Adrenalin (-)-Adrenaline (-)-Epinephrine (-)-R-Epinephrine (R)-(-)-Adnephrine (R)-(-)-Adrenaline (R)-(-)-Epinephrine (R)-(-)-Epirenamine (R)-(−)-adrenaline (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol (R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol (R)-Adrenaline (R)-Epinephrine (−)-adrenaline 02252_FLUKA 1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol 1-Adrenalin 1-Epinephrine 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol 4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol 51-43-4 51-43-4 (FREE BASE) 51028-73-0 A0173 AC-13188 AC1L1L7B ADR ADRENALINE ADROP AI3-19015 Adnephrine Adrenal Adrenalin Adrenalin (TN) Adrenalin in Oil Adrenalin-Medihaler Adrenalina Adrenalina [DCIT] Adrenaline Adrenaline (JP15) Adrenaline/Epinephrine Adrenalinum Adrenamine Adrenan Adrenapax Adrenasol Adrenatrate Adrenine Adrenodis Adrenohorma Adrenosan Adrenutol Adrin Adrine Ana-Guard Ana-Kit Antiasthmatique Asmatane Mist Asthma meter mist Asthma-nefrin Asthmahaler Mist Asthmanefrin Astmahalin Astminhal BIDD:GT0119 Balmadren Bernarenin Biorenine Bosmin Brevirenin Bronkaid Bronkaid Mist Bronkaid Suspension Mist Bupivacaine Hcl and Epinephrine C00788 CCRIS 4812 CHEBI:28918 CHEMBL679 CID5816 Chelafrin Citanest Forte Corisol D-Epifrin D-Epinephrine D00095 DB00668 Drenamist Dylephrin Dyspne-Inhal E4250_SIGMA EINECS 200-098-7 EPI E Z PEN JR EPIPEN E Z PEN EPIPEN JR Epi EZ Pen Jr Epifrin Epiglaufrin Epinefrin Epinefrin [Czech] Epinefrina Epinefrina [INN-Spanish] Epinephran Epinephrin Epinephrine Epinephrine (USP) Epinephrine (USP/INN) Epinephrine [USAN:INN:JAN] Epinephrine hydrochloride Epinephrinum Epinephrinum [INN-Latin] Epipen Epipen (TN) Epipen Auto-Injector Epipen EZ Pen Epipen Jr. Epipen Jr. Auto-Injector Epirenamine Epirenan Epirenin Epitrate Eppy Esphygmogenina Exadrin | Glaucon Glaucosan Glauposine Glycirenan HSCI1_000215 HSDB 4289 Haemostasin Haemostatin Hektalin Hemisine Hemostasin Hemostatin Hypernephrin Hyporenin IOP Intranefrin Iontocaine Isoptoepinal Kidoline L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol L-Adrenaline L-Adrenaline Base L-Epinehphrine L-Epinephrine L-Epirenamine L-Methylaminoethanolcatechol L-epinephrine LS-156 Levo-Methylaminoethanolcatechol Levoadrenaline Levoepinephrine Levorenen Levorenin Levorenine Levoreninum Lopac-E-4642 Lyodrin Lyophrin Medihaler-Epi Metanephrin Methylaminoethanolcatechol Methylarterenol Micronefrin Micronephrine MolPort-002-051-368 Mucidrina Myosthenine Mytrate NCGC00015417-01 NCGC00142615-01 NCGC00142615-03 NCGC00142615-04 NCGC00142615-05 NCGC00142615-06 NCGC00142615-07 NSC 62786 NSC62786 Nephridine Nieraline PDSP1_001120 PDSP2_001104 Paranephrin Primatene Primatene Mist R-(-)-Epinephrine R-Adrenaline RCRA waste no. P042 Racemic Epinephrine Racepinephrine Rcra waste number P042 Renagladin Renaglandin Renaglandulin Renaleptine Renalina Renoform Renostypricin Renostypticin Renostyptin SMP1_000227 ST069368 SUS-PHRINE SULFITE-FREE Scurenaline Septocaine Simplene Sindrenina Soladren Sphygmogenin Stryptirenal Styptirenal Supracapsulin Supradin Supranefran Supranephrane Supranephrine Supranol Suprarenaline Suprarenin Suprel Surenine Surrenine Sus-Phrine Sus-phrine Susphrine Sympathin I Takamina Takamine Tokamina Tonogen Twinject Twinject 0.15 Twinject 0.3 Twinject 0.30 UNII-YKH834O4BH Vaponefrin Vasoconstrictine Vasoconstrictor Vasodrine Vasoton Vasotonin adrenaline bmse000316 d-Adrenaline epinephrine l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol l-Adrenalin l-Adrenaline l-Epinephine l-Epinephrine (synthetic) l-Epirenamine l-Methylaminoethanolcatechol levoepinephrine nchembio747-comp9 |
| | 20 | | Cytarabine | approved, investigational | Phase 2, Phase 3 | 1117 | 147-94-4 | 6253 | (beta-D-Arabinofuranosyl)cytosine (beta-D-arabinofuranosyl)cytosine 1-.beta.-D-arabinofuranosyl-cytosine 1-Arabinofuranosylcytosine 1-beta -D-Arabinofaranosylcytosine 1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone 1-beta -D-Arabinofuranosylcytosine 1-beta-D-Arabinofaranosylcytosine 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone 1-beta-D-Arabinofuranosyl-Cytosine 1-beta-D-Arabinofuranosylcytosine 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside 1-beta-D-Arabinosyl-Cytosine 1-beta-D-Arabinosylcytosine 147-94-4 1beta -Arabinofuranasylcytosine 1beta -D-Arabinofuranosylcytosine 1beta -D-Arabinosylcytosine 1beta-Arabinofuranasylcytosine 1beta-D-Arabinofuranosylcytosine 1beta-D-Arabinosylcytosine 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl- [CAS] 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl 30399_FLUKA 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech] 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech] 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one 69-74-9 (hydrochloride) AC-1075 AC1L1M4F AC1Q52OJ AI3-52329 AR3 Alexan Ara-C Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine Ara-Cytidine AraC Arabinocytidine Arabinofuranosylcytosine Arabinosyl Cytosine Arabinosylcytosine Arabitin Aracytidine Aracytin Aracytine Arafcyt BIDD:GT0371 BIDD:PXR0139 BTB15125 Beta-cytosine arabinoside C02961 C1768_SIGMA C2035 C9H13N3O5 CCRIS 913 CHEBI:28680 CHEMBL803 CHX 3311 CID6253 CPD000449317 CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9) Citarabina Citarabina [INN-Spanish] Cytarabin Cytarabina Cytarabine (JP15/USP/INN) Cytarabine [USAN:INN:BAN:JAN] | Cytarabine liposome injection Cytarabinoside Cytarabinum Cytarabinum [INN-Latin] Cytarbel Cytonal Cytosar Cytosar-U Cytosine 1-beta-D-arabinofuranoside Cytosine arabinofuranoside Cytosine arabinose Cytosine arabinoside Cytosine arabinoside (VAN) Cytosine beta-D-arabinofuranoside Cytosine beta-D-arabinofuranoside hydrochloride Cytosine beta-D-arabinoside Cytosine, beta -D-arabinoside Cytosine, beta-D-arabinoside Cytosine-1-beta-D-arabinofuranoside Cytosine-1-beta-D-arabinofuranoside hydrochloride Cytosine-beta -D-arabinofuranoside Cytosine-beta -arabinoside Cytosine-beta-D-arabinofuranoside Cytosine-beta-arabinoside Cytosinearabinoside D00168 DB00987 DepoCyte Depocyt Depocyt (TN) Depocyt (liposomal) Depocyte EINECS 205-705-9 Erpalfa FT-0082880 HMS2051K19 HMS2090A18 HSDB 3049 Intrathecal (injected into the spinal fluid) DepoCyt Intrathecal cytarabine (also known as ara-C) Iretin LS-860 Lopac0_000316 MLS000758310 MLS001066340 MolPort-001-792-509 NCGC00093356-03 NCGC00093356-04 NCGC00093356-05 NCI-C04728 NSC 287459 NSC287459 S1648_Selleck SAM001247012 SMR000449317 SR-01000075773-3 Spongocytidine TL8001048 Tarabine U 19920A U-19,920 U-19920 UNII-04079A1RDZ Udicil ZINC03795098 beta -D-arabinosylcytosine beta -arabinosylcytosine beta -cytosine arabinoside beta-Ara C beta-Ara c beta-Arabinosylcytosine beta-Cytosine arabinoside beta-D-Arabinosylcytosine cytarabine cytarabine liposome injection cytosine-β-D-arabinofuranoside |
| | 21 | | Vincristine | approved, investigational | Phase 2, Phase 3 | 922 | 2068-78-2, 57-22-7 | 5978 | 22-Oxovincaleukoblastin 22-Oxovincaleukoblastine 28379-27-3 57-22-7 AC1L1LJC C07204 C46H56N4O10 CCRIS 5763 CHEBI:28445 CID5978 D08679 DB00541 EINECS 200-318-1 HMS2090E19 HSDB 3199 Indole alkaloid LCR LS-228 Leurocristine Lilly 37231 (1:1 sulfate salt) Liposomal Vincristine Marqibo NCGC00163700-01 NCI-C04864 NCI60_026703 NSC-67574 Onco TCS | Oncovin Oncovin (1:1 sulfate salt) Oncovine Tecnocris Tecnocris (TN) UNII-5J49Q6B70F VCR VIN Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine Vincasar Vincasar (1:1 sulfate salt) Vincasar PFS Vincrex Vincrex (1:1 sulfate salt) Vincristin Vincristina Vincristina [DCIT] Vincristine (INN) Vincristine Sulfate Vincristine Sulfate PFS Vincristine [INN:BAN] Vincristinum Vincristinum [INN-Latin] Vincrstine Vincrystine Vinkristin Z-D-Val-Lys(Z)-OH vincristine | |
| | 22 | | Cladribine | approved, investigational | Phase 2, Phase 3 | 73 | 4291-63-8 | 20279 | (2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol 2 Chlorodeoxyadenosine 2'-Deoxy-2-chloroadenosine 2-CdA 2-Chloro-2'-deoxy-beta-adenosine 2-Chloro-2'-deoxyadenosine 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine 2-Chlorodeoxyadenosine 2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine 2-chloro-Deoxyadenosine 2-chloro-deoxyadenosine 24757-90-2 2CdA 2ClAdo 4291-63-8 AC-7591 AC1L2FXP Adenosine, 2-chloro-2'-deoxy BRN 0624220 C10H12ClN5O3.C3H8 CHEBI:567361 CHEMBL1619 CID20279 CL9 CPD000058553 Chlorodeoxyadenosine Cladarabine Cladaribine Cladribina Cladribine Cladribine (JAN/USAN/INN) Cladribine [USAN:INN:BAN] Cladribinum | CldAdo D01370 D017338 DB00242 FT-0080707 HMS2052K13 HSDB 7564 LS-15109 Leustat Leustatin Leustatin (TN) Leustatin, 2-chlorodeoxyadenosine, Cladribine Litak MLS000028377 MLS000028484 MLS000759397 MLS001077345 MolPort-002-054-532 MolPort-005-935-074 Movectro Mylinax NCGC00022567-05 NCGC00164384-01 NSC 105014 NSC 105014-F NSC-105014 RWJ 26251 RWJ-26251 RWJ-26251-000 S1199_Selleck SAM001246526 SMR000058553 UNII-47M74X9YT5 ZINC03798064 cladribina cladribine cladribinum |
| | 23 | | Vinblastine | approved | Phase 2, Phase 3 | 420 | 865-21-4 | 13342, 241903 | (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE (2xi,3beta,4'beta,19xi)-vincaleukoblastine (3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-methyl 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-1H-indolizino(8,1-cd)carbazole-5-carboxylate 143-67-9 1z2b 29060-LE 865-21-4 AC-20335 AC1L21JC AC1L68D2 AC1MXZJ2 BIDD:PXR0201 BRD-K01188359-065-02-5 BSPBio_001228 BSPBio_003594 Bio-0111 C07201 C46H58N4O9 CCRIS 9002 CHEBI:171516 CHEBI:27375 CHEMBL159 CHEMBL607706 CID13342 CID241903 CID3823887 CID6710780 D08675 DB00570 EINECS 212-734-0 HMS2090K05 HSDB 3263 KBio3_003033 LS-1859 LS-187263 MolPort-002-518-262 | MolPort-005-910-359 NCGC00022585-04 NCGC00181127-01 NCI-C04842 NCI60_004200 NChemBio.2007.10-comp22 NDC 0002-1452-01 NSC 47842 Neuro_000020 Nincaluicolflastine Rozevin SPBio_000680 STOCK1N-38480 Spectrum2_000890 Spectrum3_001994 UNII-5V9KLZ54CY VLB VR-8 Velban Velbe Vinblastin Vinblastina Vinblastina (TN) Vinblastina [DCIT] Vinblastina [Dcit] Vinblastine Vinblastine (INN) Vinblastine Sulfate Vinblastine [INN:BAN] Vinblastinum Vinblastinum [INN-Latin] Vincaleucoblastin Vincaleucoblastine Vincaleukoblastine Vincoblastine nchembio873-comp22 vinblastine | |
| | 24 | | Methylprednisolone | approved, vet_approved | Phase 2, Phase 3 | 1193 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone |
| | 25 | | Prednisone | approved, vet_approved | Phase 2, Phase 3 | 1398 | 53-03-2 | 5865 | (1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione .delta. E .delta.(sup1)-Cortisone .delta.-Cortelan .delta.-Cortisone .delta.-Cortone .delta.-E .delta.1-Cortisone .delta.1-Dehydrocortisone .delta.sone 1,2-Dehydrocortisone 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione 1-Cortisone 1-Dehydrocortisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione 53-03-2 68-59-7 81552_FLUKA AC-11112 AC1L1LB2 AC1Q29EZ ACon0_000082 ACon1_000297 AI3-52939 Adasone Ancortone Apo-Prednisone Apo-prednisone BPBio1_000323 BRD-K85883481-001-04-2 BSPBio_000293 Betapar Bicortone Bio-0649 C07370 C21H26O5 CCRIS 2646 CHEBI:8382 CHEMBL635 CID5865 CPD001227202 Cartancyl Colisone Cortan Cortancyl Cortidelt Cotone DB00635 Dacorten Dacortin Decortancyl Decortin Decortisyl Dehydrocortisone Dekortin Delcortin Dellacort Dellacort A Delta Cortelan Delta E Delta E. Delta-Cortelan Delta-Dome Delta-cortelan Delta-cortisone Delta-cortone Delta-dome Deltacortene Deltacortisone Deltacortone Deltasone Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone Deltison Deltisona Deltisone Deltra Di-Adreson Diadreson EINECS 200-160-3 Econosone Encorton Encortone Enkortolon Enkorton Fernisone Fiasone HMS1568O15 HMS2090J13 HSDB 3168 Hostacortin In-Sone Incocortyl | Juvason Kortancyl LMST02030180 LS-1325 Liquid Pred Lisacort Lodotra MEGxm0_000443 MLS001061265 MLS001304073 MLS001335907 MLS001335908 MLS002154191 MLS002207083 Me-Korti Metacortandracin Meticorten Meticorten (Veterinary) Metrevet (Veterinary) MolPort-001-740-041 NCGC00090766-01 NCGC00090766-02 NCGC00090766-03 NCI-C04897 NCI60_000008 NSC 10023 NSC10023 Nisona Nizon Novoprednisone Nurison Orasone Origen Prednisone P1276 P6254_SIGMA PRD Panafcort Panasol Paracort Parmenison Pehacort Precort Predeltin Prednicen-M Prednicorm Prednicort Prednicot Prednidib Prednilonga Prednison Prednisona Prednisona [INN-Spanish] Prednisone Prednisone Intensol Prednisone [INN:BAN] Prednisonum Prednisonum [INN-Latin] Prednitone Prednizon Prednovister Presone Prestwick0_000077 Prestwick1_000077 Prestwick2_000077 Prestwick3_000077 Prestwick_405 Pronison Pronisone Rectodelt Retrocortine S1622_Selleck SAM002264641 SK-Prednisone SMR000718760 SMR001227202 SPBio_002214 Servisone Sone Sterapred Supercortil U 6020 UNII-VB0R961HZT Ultracorten Ultracortene WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ Winpred Wojtab ZINC03875357 Zenadrid Zenadrid (veterinary) Zenadrid [veterinary] delta cortelan delta(sup 1)-Cortisone delta(sup 1)-Dehydrocortisone delta-1-Cortisone delta-1-Dehydrocortisone delta-Cortisone delta-Cortone | |
| | 26 | | Prednisolone | approved, vet_approved | Phase 2, Phase 3 | 1193 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol | MLS001304083 MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 27 | | Indomethacin | approved, investigational | Phase 2, Phase 3 | 116 | 53-86-1 | 3715 | 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid 1z9h 37242-43-6 503560-73-4 53-86-1 74252-25-8 (hydrochloride salt, tri-hydrate) 7681-54-1 (hydrochloride salt) 91853-74-6 AB00052022 AC-532 AC1L1GJQ AKOS000592893 Aconip Aconip (TN) Amuno Apo-Indomethacin Arthrexin Artracin Artrinovo Artrivia BIDD:GT0132 BIM-0050670.0001 BPBio1_000160 BRD-K57222227-001-06-1 BRN 0497341 BSPBio_000144 BSPBio_001149 BSPBio_002176 Bio-0704 Bio2_000405 Bio2_000885 Bonidin Bonidon Bonidon Gel C01926 CAS-53-86-1 CCRIS 3502 CHEBI:49662 CHEMBL6 CID3715 CPD-10545 Catlep Chibro-amuno Chrono-indicid Chrono-indocid Confortid D00141 DB00328 DESMETHYL INDOMETHACIN DivK1c_000271 Dolcidium Dolcidium PL Dolovin Durametacin EINECS 200-186-5 EU-0100692 Elmetacin Flexin continus HMS1362I11 HMS1568H06 HMS1792I11 HMS1920F21 HMS1990I11 HMS2089N19 HMS2091N09 HMS500N13 HSDB 3101 Hicin I 7378 I0655 I7378_SIGMA I8280_SIGMA IDI1_000271 IDI1_002160 IMN IN1454 Idomethine Imbrilon Inacid Indacin Indameth Indmethacine Indo-Lemmon Indo-Spray Indo-phlogont Indo-rectolmin Indo-tablinen Indocid Indocid (pharmaceutical) Indocid Pda Indocid Sr Indocin Indocin (TN) Indocin I.V Indocin I.V. Indocin Sr Indolar SR Indomecol Indomed Indomee Indomet 140 Indometacin Indometacin (JP15/INN) Indometacina Indometacina [INN-Spanish] Indometacine Indometacine [INN-French] Indometacinum | Indometacinum [INN-Latin] Indometacyna Indometacyna [Polish] Indomethacin Indomethacin & MAP-30 Indomethacin (USP) Indomethacin [USAN:BAN] Indomethacin, Indochron E-R, Indocin-SR, Indocid, Indocin, Indomethacin Indomethacine Indomethacinum Indomethancin Indomethazine Indomethegan Indomethine Indometicina Indometicina [Spanish] Indomo Indomod Indoptic Indoptol Indorektal Indoxen Inflazon Infrocin Inteban sp KBio1_000271 KBio2_000489 KBio2_001399 KBio2_003057 KBio2_003967 KBio2_005625 KBio2_006535 KBio3_000897 KBio3_000898 KBio3_001396 KBioGR_000395 KBioGR_000489 KBioSS_000489 KBioSS_001399 L000959 LS-187 LS-82147 Lausit Liometacen Lopac-I-7378 Lopac0_000692 MLS000069402 MLS000758212 MLS001074194 Metacen Metartril Methazine Metindol Mezolin Miametan Mikametan Mobilan MolMap_000032 MolPort-000-917-894 NCGC00015562-01 NCGC00015562-02 NCGC00015562-03 NCGC00015562-08 NCGC00015562-19 NCGC00024135-02 NCGC00024135-04 NCGC00024135-05 NCGC00024135-06 NCGC00024135-07 NCGC00024135-08 NCGC00024135-09 NCGC00024135-11 NCI-C56144 NCI60_041708 NINDS_000271 Novo-Methacin Novomethacin Oprea1_686105 Prestwick0_000272 Prestwick1_000272 Prestwick2_000272 Prestwick3_000272 Prestwick_597 Reumacide Rhemacin LA Rheumacin LA S00108 S1723_Selleck SMR000058195 SMR000449290 SPBio_000979 SPBio_002363 SPECTRUM1500350 Sadoreum Spectrum2_000970 Spectrum3_000468 Spectrum4_000018 Spectrum5_000868 Spectrum_000919 Tannex Tocris-1708 UNII-XXE1CET956 UPCMLD-DP023 UPCMLD-DP023:001 USAN Vonum indometacin indomethacin nchembio.147-comp11 {1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid |
| | 28 | | Methotrexate | approved | Phase 2, Phase 3 | 1551 | 1959-05-2, 59-05-2 | 126941 | 4-amino-10-methylfolic acid 4-amino-N(10)-methylpteroylglutamic acid Abitrexate Amethopterin Amethopterine Antifolan Arbitrexate Emtexate Folex HDMTX L-Amethopterin Ledertrexate MTX Metatrexan | Methopterin Methotextrate Methotrate Methotrexat Methotrexate Sodium Methotrexatum Methylaminopterin Methylaminopterinum Metotrexato Mexate Méthotrexate N-Bismethylpteroylglutamic Acid N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid Rheumatrex Trexall | |
| | 29 | | Lidocaine | approved, vet_approved | Phase 2, Phase 3 | 1317 | 137-58-6 | 3676 | .alpha.-(Diethylamino)-2,6-acetoxylidide .alpha.-Diethylamino-2,6-dimethylacetanilide .alpha.-Diethylaminoaceto-2,6-xylidide .omega.-Diethylamino-2,6-dimethylacetanilide 137-58-6 2-(Diethylamino)-2',6'-acetoxylidide 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide 2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide 4-12-00-02538 (Beilstein Handbook Reference) 6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE)) 6108-05-0 (mono-hydrochloride, mono-hydrate) 73-78-9 (mono-hydrochloride) AB00053581 AC-10282 AC1L1GGQ AC1Q2Z7J AKOS001026768 ARONIS23855 After Burn Double Strength Gel After Burn Double Strength Spray After Burn Gel After Burn Spray Alphacaine Anestacon Anestacon Jelly BIDD:GT0342 BPBio1_000197 BRD-K52662033-001-02-6 BRD-K52662033-003-05-5 BRN 2215784 BSPBio_000179 BSPBio_001359 BSPBio_003004 Bio-0767 Bio1_000379 Bio1_000868 Bio1_001357 Bio2_000079 Bio2_000559 C07073 C14H22N2O CAS-73-78-9 CDS1_000283 CHEBI:6456 CHEMBL79 CID3676 CPD000058189 Cappicaine Cito optadren Cuivasil D00358 DB00281 Dalcaine Dentipatch Dentipatch (TN) DermaFlex Diethylaminoaceto-2,6-xylidide Dilocaine DivK1c_000174 DivK1c_001323 Duncaine EINECS 205-302-8 ELA-Max EMBOLEX Emla Emla Cream Esracaine FT-0082378 Gravocain HMS1791D21 HMS1989D21 HMS2051C21 HMS2089E15 HMS548M19 HSDB 3350 I01-2704 IDI1_000174 IDI1_033829 Isicaina Isicaine Jetocaine KBio1_000174 KBio2_000079 KBio2_001598 KBio2_002647 KBio2_004166 KBio2_005215 KBio2_006734 KBio3_000157 KBio3_000158 KBio3_002224 KBioGR_000079 KBioGR_000599 KBioSS_000079 KBioSS_001598 L-Caine L0156 L1026_SIGMA L7757_SIGMA LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE) LIDOPEN LQZ | LS-805 Lanabiotic Leostesin Lida-Mantle Lidocaina Lidocaina [INN-Spanish] Lidocaine (JP15/USP/INN) Lidocaine (VAN) Lidocaine Carbonate Lidocaine Hydrocarbonate Lidocaine Monohydrochloride Lidocaine [USAN:INN:JAN] Lidocainum Lidocainum [INN-Latin] Lidocaton Lidoderm Lidoject-1 Lidoject-2 Lignocaine Lignocainum Lingocaine Lopac-L-5647 Lopac0_000669 MLS000069724 MLS000758263 MLS001074177 Maricaine Maybridge1_002571 MolPort-001-783-478 N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide NCGC00015611-01 NCGC00015611-02 NCGC00015611-03 NCGC00015611-04 NCGC00015611-14 NCGC00022176-05 NCGC00022176-06 NCGC00022176-07 NCGC00022176-08 NCGC00022176-09 NINDS_000174 NSC 40030 NSC40030 Norwood Sunburn Spray Octocaine Octocaine-100 Octocaine-50 Prestwick0_000050 Prestwick1_000050 Prestwick2_000050 Prestwick3_000050 Remicaine Rocephin Kit Rucaina S1357_Selleck SAM001247018 SMR000058189 SPBio_001525 SPBio_002100 STK552033 Solarcaine Solarcaine aloe extra burn relief cream Solcain Spectrum2_001343 Spectrum3_001392 Spectrum4_000070 Spectrum5_001549 Spectrum_001118 UNII-98PI200987 WLN: 2N2 & 1VMR B1 F1 Xilina Xilocaina Xilocaina [Italian] Xllina Xycaine Xylestesin Xylesthesin Xylocain Xylocaine Xylocaine (TN) Xylocaine 5% Spinal Xylocaine CO2 Xylocaine Dental Ointment Xylocaine Endotracheal Xylocaine Test Dose Xylocaine Viscous Xylocaine-MPF Xylocaine-MPF with Glucose Xylocaine-Mpf Xylocaine-Mpf with Glucose Xylocard Xylocitin Xyloneural (free base) Xylotox Zilactin-L Zingo alfa-Dietilamino-2,6-dimetilacetanilide alfa-Dietilamino-2,6-dimetilacetanilide [Italian] alpha-Diethylamino-2,6-dimethylacetanilide alpha-diethylamino-2,6-dimethylacetanilide lidocaine nchembio.65-comp16 α-diethylamino-2,6-dimethylacetanilide | |
| | 30 | | tannic acid | approved, Nutraceutical | Phase 3 | 2016 | | | | 31 | | leucovorin | approved, Nutraceutical | Phase 2, Phase 3 | 3235 | 58-05-9 | 54575, 6560146, 143 | (5-formyl-5,6,7,8-tetrahydropteroyl)glutamate (6R,S)-5-Formyltetrahydrofolate 10-Formyl-7,8-dihydrofolate 10-Formyl-7,8-dihydrofolic acid 5-Formyl-5,6,7,8-tetrahydrofolate 5-Formyl-5,6,7,8-tetrahydrofolic acid 5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid 5-Formyltetrahydrofolate 5-Formyltetrahydrofolic acid 5-Formyltetrahydropteroylglutamate 5-Formyltetrahydropteroylglutamic acid 5-formyltetrahydrofolic acid Acide folinique Calcium citrovorum factor Calcium folinate Citrovorum factor Folinate Folinic acid Folinic acid calcium salt | Folinic acid calcium salt USP27 Folinic acid-SF L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid L-Leucovorin L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid L-leucovorin Leucal Leucovorin calcium Leucovorin folinic acid Leucovorinum Leukovorin Levoleucovorin N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid N5-Formyl-5,6,7,8-tetrahydrofolate N5-Formyl-5,6,7,8-tetrahydrofolic acid N5-Formyl-THF N5-Formyltetrahydrofolate N5-Formyltetrahydrofolic acid Welcovorin Wellcovorin folinate |
| | 32 | | Folic Acid | approved, nutraceutical, vet_approved | Phase 2, Phase 3, Phase 1 | 4392 | 59-30-3 | 6037 | (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid 01769_FLUKA 2d0k 33609-88-0 36653-55-1 (mono-potassium salt) 59-30-3 6484-89-5 (mono-hydrochloride salt) AC-11682 AC1L1LNX AI3-26387 AKOS000503224 ARONIS014410 Acfol (Spain) Acide folique Acide folique [INN-French] Acido folico Acido folico [INN-Spanish] Acidum folicum Acidum folicum [INN-Latin] Acifolic Antianemia factor Apo-Folic BIDD:ER0563 BIDD:GT0641 BIF0608 BPBio1_000654 BSPBio_000594 BSPBio_002338 C00504 C20H20N6O6 CAS-59-30-3 CCRIS 666 CHEBI:27470 CHEMBL1622 CID6037 CPD000471860 Cytofol D00070 DB00158 DivK1c_000494 Dosfolat B activ EINECS 200-419-0 F0043 F7876_SIAL F7876_SIGMA F8758_SIGMA F8798_SIAL F8890_SIGMA FOL Facid Factor U Folacid Folacin Folaemin Folaemin [Netherlands] Folan Folasic (Australia) Folate Folbal Folcidin Folcidin (VAN) Folcysteine Foldine Foldine [France] Folettes Foliamin Folic Folic acid Folic acid (JP15/USP/INN) Folic acid (TN) Folic acid [BAN:INN:JAN] Folic acid [INN:BAN:JAN] Folic acid dihydrate Folicet Folicet (TN) Folico Folico (Italy) Folina Folina (Italy) Folipac Folsaeure | Folsan Folsaure Folsav Folvite Folvron Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L HMS1921D20 HMS2092N17 HMS501I16 HSDB 2002 IDI1_000494 InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s Incafolic KBio1_000494 KBio2_001861 KBio2_004429 KBio2_006997 KBio3_001558 KBioGR_002222 KBioSS_001861 Kyselina listova Kyselina listova [Czech] LS-2157 Liver Lactobacillus casei factor MLS001304016 MLS001335861 Millafol Mission prenatal Mittafol MolPort-004-285-551 N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid N-Pteroyl-L-glutamic acid N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid NCGC00016265-01 NCGC00142391-01 NINDS_000494 NSC 3073 Nifolin Nifolin [Denmark] Novofolacid Novofolacid [Canada] PGA PGA (VAN) Prestwick3_000627 Prestwick_230 PteGlu Pteroyl-L-glutamate Pteroyl-L-glutamic acid Pteroyl-L-monoglutamate Pteroyl-L-monoglutamic acid Pteroylglutamate Pteroylglutamic acid Pteroylmonoglutamate Pteroylmonoglutamic acid SAM002264616 SDCCGMLS-0066738.P001 SMP2_000137 SMR000471860 SPBio_001357 SPECTRUM1502020 Serum Folate Level Spectrum2_001459 Spectrum3_000749 Spectrum4_001751 Spectrum5_000602 Spectrum_001381 UNII-935E97BOY8 Usaf cb-13 Vitamin B11 Vitamin B9 Vitamin Bc Vitamin Be Vitamin M bmse000299 folic acid nchembio.108-comp10 | |
| | 33 | | Hydrocortisone 17-butyrate 21-propionate | | Phase 2, Phase 3, Early Phase 1 | 667 | | | | 34 | | Anti-Inflammatory Agents | | Phase 2, Phase 3, Early Phase 1 | 10729 | | | | 35 | | Hydrocortisone acetate | | Phase 2, Phase 3, Early Phase 1 | 667 | | | | 36 | | Anesthetics | | Phase 2, Phase 3 | 9596 | | | | 37 | | Hypoglycemic Agents | | Phase 3, Early Phase 1 | 5896 | | | | 38 | | Cortisol succinate | | Phase 2, Phase 3, Early Phase 1 | 667 | | | | 39 | | Racepinephrine | | Phase 2, Phase 3 | 985 | | | | 40 | | Androgens | | Phase 2, Phase 3 | 1321 | | | | 41 | | Epinephryl borate | | Phase 2, Phase 3 | 985 | | | | 42 | | Estrogen Antagonists | | Phase 2, Phase 3 | 1349 | | | | 43 | | Antihypertensive Agents | | Phase 3 | 4207 | | | | 44 | | Autonomic Agents | | Phase 3, Phase 2 | 10150 | | | | 45 | | Neurotransmitter Agents | | Phase 3, Phase 2 | 18340 | | | | 46 | | Sympatholytics | | Phase 3 | 580 | | | | 47 | | Analgesics | | Phase 3, Phase 2 | 11733 | | | | 48 | | Adrenergic alpha-Agonists | | Phase 3, Phase 2 | 1734 | | | | 49 | | Adrenergic Agents | | Phase 3, Phase 2 | 5352 | | | | 50 | | Adrenergic Agonists | | Phase 3, Phase 2 | 3027 | | |
Interventional clinical trials: (show top 50)
(show all 229)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Growth Hormone and Brain Functioning After Traumatic Brain Injury | Unknown status | NCT01699308 | Phase 4 | | 2 | Selenium Supplementation in Pregnancy | Unknown status | NCT01465867 | Phase 4 | | 3 | Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen® | Completed | NCT01187550 | Phase 4 | | 4 | National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients | Completed | NCT00097513 | Phase 4 | | 5 | Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD) | Completed | NCT00097526 | Phase 4 | | 6 | Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia | Completed | NCT00140413 | Phase 4 | | 7 | Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.) | Completed | NCT01605331 | Phase 4 | | 8 | Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients | Completed | NCT01562834 | Phase 4 | | 9 | Easypod United States User Trial | Completed | NCT00689260 | Phase 4 | | 10 | A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency | Completed | NCT00455884 | Phase 4 | | 11 | Predictive Markers in GHD and TS Children Treated With SAIZEN® | Completed | NCT00256126 | Phase 4 | | 12 | Growth Hormone and Endothelial Function in Children | Completed | NCT00373386 | Phase 4 | | 13 | Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency | Completed | NCT00490191 | Phase 4 | | 14 | An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD) | Completed | NCT01806298 | Phase 4 | | 15 | Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method | Completed | NCT00990340 | Phase 4 | | 16 | Growth Hormone and Glucose Metabolism | Completed | NCT00929799 | Phase 4 | | 17 | Liquid Somatropin Formulation in Children With Growth Hormone Deficiency | Completed | NCT00567385 | Phase 4 | | 18 | IGF1 Generation Test | Completed | NCT00145457 | Phase 4 | | 19 | A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood | Completed | NCT01157793 | Phase 4 | | 20 | Effect of 5 Years of GH Replacement on Atherosclerosis | Completed | NCT00462475 | Phase 4 | | 21 | Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome? | Completed | NCT01298180 | Phase 4 | | 22 | GH and Cardiovascular Risk Factors | Completed | NCT01877512 | Phase 4 | | 23 | Anterior Pituitary Hormone Replacement in Traumatic Brain Injury | Completed | NCT00957671 | Phase 4 | | 24 | A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood | Completed | NCT00212758 | Phase 4 | | 25 | First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study | Completed | NCT01419249 | Phase 4 | | 26 | Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents | Completed | NCT01245374 | Phase 4 | | 27 | Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation | Completed | NCT00360074 | Phase 4 | | 28 | Epidemiology Study on Insulin-like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study) | Completed | NCT00710307 | Phase 4 | | 29 | Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old | Completed | NCT01853566 | Phase 4 | | 30 | Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children | Recruiting | NCT02314676 | Phase 4 | | 31 | Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency | Recruiting | NCT02908958 | Phase 4 | | 32 | Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency | Recruiting | NCT02976675 | Phase 4 | | 33 | Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I) | Recruiting | NCT02380235 | Phase 4 | | 34 | Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. | Recruiting | NCT03015909 | Phase 4 | | 35 | A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency | Active, not recruiting | NCT02311894 | Phase 4 | | 36 | A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury | Terminated | NCT00638053 | Phase 4 | | 37 | Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency | Terminated | NCT01698944 | Phase 4 | | 38 | Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury | Terminated | NCT00555009 | Phase 4 | | 39 | Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury. | Withdrawn | NCT00432263 | Phase 4 | | 40 | Treatment of Children With Insufficient Secretion of Growth Hormone | Unknown status | NCT00271518 | Phase 3 | | 41 | Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children | Completed | NCT00102817 | Phase 3 | | 42 | Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency | Completed | NCT00109733 | Phase 3 | | 43 | Investigation of a New, Oral Growth Hormone Secretagogue, Macimorelin (AEZS-130) as a Growth Hormone Stimulation Test. | Completed | NCT00448747 | Phase 3 | | 44 | Sustained Release Formulation of Somatropin (rDNA Origin)for Injection | Completed | NCT00600808 | Phase 2, Phase 3 | | 45 | Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients | Completed | NCT00570011 | Phase 3 | | 46 | Practicability and Acceptability of Stylomax® in Children | Completed | NCT00476385 | Phase 3 | | 47 | Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm | Completed | NCT00163189 | Phase 3 | | 48 | Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents | Completed | NCT00156143 | Phase 3 | | 49 | Growth Hormone and Chromosome 18q- and Abnormal Growth | Completed | NCT00134420 | Phase 3 | | 50 | Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary | Completed | NCT00174278 | Phase 3 |
|
